Nicholas Hoffman & Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $326K | Hold |
732
| – | – | 0.01% | 246 |
|
|
2025
Q1 | $355K | Hold |
732
| – | – | 0.01% | 229 |
|
|
2024
Q4 | $295K | Hold |
732
| – | – | 0.01% | 242 |
|
|
2024
Q3 | $340K | Sell |
732
-100
| -12% | -$46.5K | 0.01% | 236 |
|
|
2024
Q2 | $390K | Buy |
832
+100
| +14% | +$46.9K | 0.02% | 217 |
|
|
2024
Q1 | $306K | Buy |
732
+96
| +15% | +$40.1K | 0.02% | 238 |
|
|
2023
Q4 | $259K | Buy |
636
+24
| +4% | +$9.77K | 0.02% | 247 |
|
|
2023
Q3 | $213K | Hold |
612
| – | – | 0.02% | 256 |
|
|
2023
Q2 | $215K | Sell |
612
-289
| -32% | -$102K | 0.01% | 255 |
|
|
2023
Q1 | $284K | Hold |
901
| – | – | 0.03% | 225 |
|
|
2022
Q4 | $260K | Hold |
901
| – | – | 0.03% | 227 |
|
|
2022
Q3 | $261K | Hold |
901
| – | – | 0.01% | 216 |
|
|
2022
Q2 | $254K | Buy |
901
+17
| +2% | +$4.79K | 0.01% | 223 |
|
|
2022
Q1 | $231K | Buy |
+884
| New | +$231K | 0.01% | 258 |
|